Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Heverin

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
BMC Bioinformatics|September 16, 2024
Mining impactful discoveries from the biomedical literatureErwan Moreau, Orla Hardiman, Mark Heverin, et al.
Neurology|May 10, 2024
Irish Amyotrophic Lateral Sclerosis Incidence: Age, Period, and Cohort Effects Using a Partial Least Squares Regression ModelRobert McFarlane, Mark Heverin, Cathal Walsh, et al.
JAMA Neurology|July 23, 2019
Lifetime Risk and Heritability of Amyotrophic Lateral SclerosisMarie Ryan, Mark Heverin, Russell L McLaughlin, et al.
Health and Quality of Life Outcomes|November 23, 2020
Individual quality of life in spousal ALS patient-caregiver dyadsMiriam Galvin, Tommy Gavin, Iain Mays, et al.
BMJ Open|January 20, 2023
Care, burden and self-described positive aspects of caring in amyotrophic lateral sclerosis: an exploratory, longitudinal, mixed-methods studyÉilís Conroy, Polly Kennedy, Mark Heverin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2014
Fecundity in ALSSusan Byrne, Mark Heverin, Peter Bede, et al.
Neurology|September 25, 2023
Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021Robert McFarlane, Colm Peelo, Miriam Galvin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 27, 2016
What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosisJames Rooney, Tom Burke, Alice Vajda, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2013
Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosisSusan Byrne, Mark Heverin, Marwa Elamin, et al.
Scientific Reports|June 11, 2021
Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learningAnna Markella Antoniadi, Miriam Galvin, Mark Heverin, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
BMC Bioinformatics|September 16, 2024
Mining impactful discoveries from the biomedical literatureErwan Moreau, Orla Hardiman, Mark Heverin, et al.
Neurology|May 10, 2024
Irish Amyotrophic Lateral Sclerosis Incidence: Age, Period, and Cohort Effects Using a Partial Least Squares Regression ModelRobert McFarlane, Mark Heverin, Cathal Walsh, et al.
JAMA Neurology|July 23, 2019
Lifetime Risk and Heritability of Amyotrophic Lateral SclerosisMarie Ryan, Mark Heverin, Russell L McLaughlin, et al.
Health and Quality of Life Outcomes|November 23, 2020
Individual quality of life in spousal ALS patient-caregiver dyadsMiriam Galvin, Tommy Gavin, Iain Mays, et al.
BMJ Open|January 20, 2023
Care, burden and self-described positive aspects of caring in amyotrophic lateral sclerosis: an exploratory, longitudinal, mixed-methods studyÉilís Conroy, Polly Kennedy, Mark Heverin, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2014
Fecundity in ALSSusan Byrne, Mark Heverin, Peter Bede, et al.
Neurology|September 25, 2023
Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021Robert McFarlane, Colm Peelo, Miriam Galvin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 27, 2016
What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosisJames Rooney, Tom Burke, Alice Vajda, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2013
Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosisSusan Byrne, Mark Heverin, Marwa Elamin, et al.
Scientific Reports|June 11, 2021
Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learningAnna Markella Antoniadi, Miriam Galvin, Mark Heverin, et al.
Pageof 9